[{"Assets_0_Q2_USD":507174000.0,"CommonStockSharesOutstanding_0_Q2_shares":60467380.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-64584000.0,"NetIncomeLoss_1_Q2_USD":-44498000.0,"NetIncomeLoss_2_Q2_USD":-77109000.0,"StockholdersEquity_0_Q2_USD":441444000.0,"Ticker":"GOSS","CIK":"1728117","name":"GOSSAMER BIO, INC.","OfficialName":"Gossamer Bio Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"635524809.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]